| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 07/01/2008 | US7393677 Avidin-pseudotyped viral vectors and their use |
| 07/01/2008 | US7393676 3-Hydroxypropionic acid and other organic compounds |
| 07/01/2008 | US7393675 Nucleotide sequences coding sugar metabolism and oxidative phosphorylation (SMP) protein for preparation and generation of amino acid for use in foods, cosmetics and medicines; bioremediation; terpenoid biosynthesis |
| 07/01/2008 | US7393672 DNA coding for endo-β-galactosidase |
| 07/01/2008 | US7393671 Mutant carotenoid ketolases |
| 07/01/2008 | US7393669 Metabolically engineered micro-organisms having improved galactose uptake |
| 07/01/2008 | US7393664 Preparing transgenic fungal bioreator for propagation and expression of heterologous proteins |
| 07/01/2008 | US7393663 For diagnostics/forensics/gene therapy/chromosome mapping; expression vector design/secretion |
| 07/01/2008 | US7393661 Nucleic acids encoding OBG3 polypeptides |
| 07/01/2008 | US7393660 Polypeptide of given sequence; transforming or transfecting cell with expression vector; inhibits tumor necrosis factor release; anti-inflammatory |
| 07/01/2008 | US7393657 Diagnosis and treatment of cancer: I |
| 07/01/2008 | US7393655 Nucleotide sequences coding cyclic peptide receptor for use in identifying modulators for treatment of pituitary hormone, epinephrine release, gastrointestinal, cardiovascular, electrolyte balance, hypertensive, diabetic and respiratory system disorder |
| 07/01/2008 | US7393654 Nucleotide sequences coding G-protein coupled receptor (T2R) for use in identifying modulators which control bitterness; food processing and pharmocological design |
| 07/01/2008 | US7393651 Confluence regulated adhesion molecules useful in modulating vascular permeability |
| 07/01/2008 | US7393650 Using hybridoma cells to generate monoclonal antibody specific to 7-transmembrane receptor protein for use in the diagnosis, prevention and treatment of psychological and nervous system disorders |
| 07/01/2008 | US7393648 Hybrid antibodies |
| 07/01/2008 | US7393643 Method of detecting ivermectin sensitivity in a canine subject by identifying a mutation in a MDR1-encoding sequence |
| 07/01/2008 | US7393639 Methods for identifying genes and promoters of interest using the Impala transposon |
| 07/01/2008 | US7393635 Cloning double-stranded target DNA into a double stranded vector DNA without the use restriction enzymes or any joining enzyme such as ligase |
| 07/01/2008 | US7393633 Detecting biotin-containing amplified DNA using biochips; prevention and treatment of cervical cancer |
| 07/01/2008 | US7393632 Use of multiple recombination sites with unique specificity in recombinational cloning |
| 07/01/2008 | US7393540 Therapeutic peptide for prevention of microorganismal infections; enzyme inhibitors; RNA inteference; antisense agents |
| 07/01/2008 | US7393539 Therapeutic agent for prevention and treatment of bacterial infection; bactericides; genetic vaccines; immunotherapy |
| 07/01/2008 | US7393536 Nucleotide sequences coding streptococcus capsular polysaccharide antigens for use in diagnosis and prevention of infections in mammals; veterinary medicine |
| 07/01/2008 | US7393530 IL-1-like cytokine antibodies |
| 07/01/2008 | US7393527 Method for limiting the growth of cancer cells using an attenuated measles virus |
| 07/01/2008 | US7393525 Method for introducing and expressing genes in animal cells, and live invasive bacterial vectors for use in the same |
| 07/01/2008 | US7393524 Baculovirus vectors comprising a capsid polypeptide fused to a GNRH polypeptide |
| 07/01/2008 | US7393478 Therapy for human cancers using cisplatin and other drugs or genes encapsulated into liposomes |
| 07/01/2008 | US7393318 Methods and compositions for interaction trap assays |
| 06/28/2008 | CA2612505A1 High throughput genome specific molecular markers for erucic acid content genes in brassica napus (l.) |
| 06/26/2008 | WO2008076980A2 Generation of plants with altered oil, protein, or fiber content |
| 06/26/2008 | WO2008076966A1 Use of esterase genes as selectable markers for transforming plant cells |
| 06/26/2008 | WO2008076938A1 Method of making cyclic polypeptides with inteins |
| 06/26/2008 | WO2008076922A1 Modulation of plant protein levels |
| 06/26/2008 | WO2008076857A2 Method and compositions for inhibiting mage protein interaction with kap-1 |
| 06/26/2008 | WO2008076856A2 Reagents and methods for detecting cyp2d6 polymorphisms |
| 06/26/2008 | WO2008076844A2 Novel genes and rna molecules that confer stress tolerance |
| 06/26/2008 | WO2008076835A2 Generation of plants with altered oil, protein, or fiber content |
| 06/26/2008 | WO2008076834A2 Generation of plants with altered oil, protein, or fiber content |
| 06/26/2008 | WO2008076831A2 Generation of plants with altered oil, protein, or fiber content |
| 06/26/2008 | WO2008076802A2 Tobacco plants having reduced nicotine demethylase activity |
| 06/26/2008 | WO2008076557A2 Detecting cyp2d6 alleles |
| 06/26/2008 | WO2008076437A2 Activin-actrii antagonists and uses for increasing red blood cell levels |
| 06/26/2008 | WO2008076368A2 Fragment-rearranged nucleic acids and uses thereof |
| 06/26/2008 | WO2008076324A2 Compositions and methods to treat muscular & cardiovascular disorders |
| 06/26/2008 | WO2008076321A1 Engineered anti-tslp antibody |
| 06/26/2008 | WO2008076158A2 Nontoxic ricin mutant compositions and methods |
| 06/26/2008 | WO2008076127A1 Inhibitory polynucleotide compositions and methods for treating cancer |
| 06/26/2008 | WO2008076077A1 Method of early diagnosis of epstein-barr virus-related cancer and respective reagents and kits |
| 06/26/2008 | WO2008075991A2 Yeast platform construction and screening methods |
| 06/26/2008 | WO2008075914A1 Corynebacterium glutamicum enhanced expression of moaa gene encoding molybdenum cofactor biosynthesis enzyme a and method for producing l-lysine using the same |
| 06/26/2008 | WO2008075911A1 Vector for expressing nc protein of hiv and method for producing nc protein using the same |
| 06/26/2008 | WO2008075904A1 Polypeptide having methionine synthesis function, polynucleotide encoding the polypeptide, and those use |
| 06/26/2008 | WO2008075713A1 Marker for diagnosis of cancer, and target molecule for therapy |
| 06/26/2008 | WO2008075520A1 Primer and probe for detection of mycobacterium avium and method for detection of mycobacterium avium by using the primer or probe |
| 06/26/2008 | WO2008075519A1 Method of amplifying nucleic acid and method of analyzing nucleic acid by using the same |
| 06/26/2008 | WO2008075501A1 Rotary extraction container, method of identifying cell species and method of detecting gene using the same, and automatic nucleic acid extractor |
| 06/26/2008 | WO2008075483A1 Process for production of l-amino acid |
| 06/26/2008 | WO2008075363A1 Variants of vegfr and their use in the diagnosis and treatment of pregnancy associated medical conditions |
| 06/26/2008 | WO2008075352A1 Stress response genes useful for generating stress tolerant plants |
| 06/26/2008 | WO2008075349A1 Therapeutic methods using a thymus peptide |
| 06/26/2008 | WO2008075174A2 Lysosomal associated membrane protein (lamp) - like polypeptide, ligands to the same, and use of the same in the frame of detection and purification of human plasmacytoid dendritic cells |
| 06/26/2008 | WO2008075057A2 ENHANCED EXPRESSION FROM THE Pm PROMOTER |
| 06/26/2008 | WO2008074891A2 Plants having enhanced yield-related traits and a method for method for making the same |
| 06/26/2008 | WO2008074880A2 Transgenic animal model |
| 06/26/2008 | WO2008074840A2 Amino acid sequences directed against a metalloproteinase from the adam family and polypeptides comprising the same for the treatment of adam-related diseases and disorders |
| 06/26/2008 | WO2008074839A2 Amino acid sequences directed against gpcrs and polypeptides comprising the same for the treatment of gpcr-related diseases and disorders |
| 06/26/2008 | WO2008074424A2 Coding genes with a single exon for new bioactive peptides |
| 06/26/2008 | WO2008074328A2 Microrna target site blocking oligos and uses thereof |
| 06/26/2008 | WO2008074230A1 Interferon alpha mutant and its polyethylene glycol derivative |
| 06/26/2008 | WO2008074189A1 A recombinant adenovirus comprising recombinant khp50 gene and preparation method and uses thereof |
| 06/26/2008 | WO2008074182A1 Method for the detection and typing of human papillomavirus, and the reagent kit thereof |
| 06/26/2008 | WO2008074130A1 Anti-tumour immunity induction by a non-replicatmg adenovirus encoding tap-1 |
| 06/26/2008 | WO2008074116A1 Nucleic acid molecules encoding plant proteins in the c3hc4 family and methods for the alteration of plant cellulose and lignin content |
| 06/26/2008 | WO2008074115A1 Nucleic acid constructs and methods for altering plant fiber length and/or plant height |
| 06/26/2008 | WO2008074079A1 Identification of candidate vaccine antigens from dichelobacter nodosus |
| 06/26/2008 | WO2008074069A1 Sheep pigmentation |
| 06/26/2008 | WO2008074047A1 Chemokine-chaperone fusion proteins |
| 06/26/2008 | WO2008051633A8 Cropping systems for managing weeds |
| 06/26/2008 | WO2008049078B1 Nicked or gapped nucleic acid molecules and uses thereof |
| 06/26/2008 | WO2008048344A9 Bacillus anthracis antigens, vaccine compositions, and related methods |
| 06/26/2008 | WO2008048124A3 Ssl7 mutants and uses therefor |
| 06/26/2008 | WO2008043753A8 Rna antagonist compounds for the modulation of pcsk9 |
| 06/26/2008 | WO2008039357A9 Uncoupling of dna insert propagation and expression of protein for phage display |
| 06/26/2008 | WO2008031430A3 Doubly transgenic non-human mammal |
| 06/26/2008 | WO2008017646A3 Expression of genes from gram negative bacteria in fungi |
| 06/26/2008 | WO2008011584A3 Bacillus thuringiensis toxin with anti-lepidopteran activity |
| 06/26/2008 | WO2008011503A3 Use of a phage displaying a peptide from an adhesion protein for treating a disease associated with intracellular formation of protein fibrillar inclusions or aggregates |
| 06/26/2008 | WO2008006363A3 Treatment of t-cell carcinomas using bcl11b inhibitors |
| 06/26/2008 | WO2007146706A8 Modified dicamba monooxygenase enzyme and methods of its use |
| 06/26/2008 | WO2007146678A8 Method for selection of transformed cells |
| 06/26/2008 | WO2007143317A3 Compounds and methods for modulating expression of crp |
| 06/26/2008 | WO2007143316A3 Compounds and methods for modulating expression of sglt2 |
| 06/26/2008 | WO2007096779A3 Generation of heavy-chain only antibodies in transgenic animals |
| 06/26/2008 | WO2007035922A3 Aptamers to the human il-12 cytokine family and their use as autoimmune disease therapeutics |
| 06/26/2008 | WO2007013807A9 Targeting-enhanced activation of galectins |
| 06/26/2008 | WO2006040376A3 Solution for the indefinite maintenance of nucleic acids in the cell of origin thereof |
| 06/26/2008 | WO2006026570A8 Use of stem cells to generate inner ear cells |
| 06/26/2008 | WO2005120230A3 POSITIONALLY MODIFIED siRNA CONSTRUCTS |